Hirudin and thrombosis prophylaxis.
Turpie
A G
AG
HGH-McMaster Clinic, Hamilton, Ontario, Canada.
D000925:Anticoagulants / Q000627:therapeutic use*; D000990:Antithrombin III / Q000378:metabolism; D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000378:metabolism / Q000627:therapeutic use; D006622:Hip Prosthesis; D024764:Hirudin Therapy; D006629:Hirudins / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D011994:Recombinant Proteins / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D000991:Antithrombins; D006495:Heparin, Low-Molecular-Weight; D006629:Hirudins; D011994:Recombinant Proteins; D000990:Antithrombin III; C060225:desirudin